# Propel Bio Management, LLC: Form 13F holdings

An institutional investment manager in Los Angeles, CA. SEC CIK 1969764.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $191.1m
- Positions: 29 (29 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1969764/000182912626008753/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [PLAINS GP HOLDINGS LP-CL (PAGP)](/companies/pagp.md) | COMM | $30.9m | 16.2% | 1,272,360 |  | Unchanged |
| [ACHIEVE LIFE SCIENCES INC (ACHV)](/companies/achv.md) | COMM | $26.3m | 13.8% | 4,034,018 |  | Added +247,593 |
| [CORCEPT THERAPEUTICS INC (CORT)](/companies/cort.md) | COMM | $11.9m | 6.2% | 136,499 |  | Reduced −11,329 |
| [PHATHOM PHARMACEUTICALS I (PHAT)](/companies/phat.md) | COMM | $11.4m | 6.0% | 1,050,358 |  | Added +209,086 |
| [DELCATH SYSTEMS INC (DCTH)](/companies/dcth.md) | COMM | $11.0m | 5.7% | 871,460 |  | Reduced −108,238 |
| [MILESTONE PHARMACEUTICALS (MIST)](/companies/mist.md) | COMM | $10.0m | 5.2% | 7,429,590 |  | Added +3,311,269 |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | ADRS | $8.1m | 4.2% | 573,086 |  | Reduced −168,963 |
| [KYVERNA THERAPEUTICS INC (KYTX)](/companies/kytx.md) | COMM | $7.9m | 4.1% | 883,198 |  | Added +238,777 |
| [ARTIVA BIOTHERAPEUTICS IN (ARTV)](/companies/artv.md) | COMM | $6.8m | 3.5% | 696,436 |  | Added +550,067 |
| [ABEONA THERAPEUTICS INC (ABEO)](/companies/abeo.md) | COMM | $6.1m | 3.2% | 983,070 |  | Reduced −346,829 |
| [AQUESTIVE THERAPEUTICS IN (AQST)](/companies/aqst.md) | COMM | $6.0m | 3.1% | 1,442,397 |  | Added +731,409 |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COMM | $5.4m | 2.8% | 2,582,388 |  | Added +1,467,388 |
| [IMMUNIC INC (IMUX)](/companies/imux.md) | COMM | $5.0m | 2.6% | 325,022 |  | New +325,022 |
| [INVENTIVA SA - ADR (IVA)](/companies/iva.md) | COMM | $4.8m | 2.5% | 1,281,212 |  | Added +556,534 |
| [SAB BIOTHERAPEUTICS INC (SABS)](/companies/sabs.md) | COMM | $4.2m | 2.2% | 1,076,578 |  | Added +63,788 |
| [ORCHESTRA BIOMED HOLDINGS (OBIO)](/companies/obio.md) | COMM | $3.9m | 2.0% | 896,701 |  | Unchanged |
| [CELLDEX THERAPEUTICS INC (CLDX)](/companies/cldx.md) | COMM | $3.9m | 2.0% | 103,695 |  | Reduced −27,669 |
| [ZEVRA THERAPEUTICS INC (ZVRA)](/companies/zvra.md) | COMM | $3.6m | 1.9% | 253,544 |  | Reduced −28,874 |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COMM | $3.5m | 1.8% | 357,966 |  | Reduced −24,409 |
| [4D MOLECULAR THERAPEUTICS IN (FDMT)](/companies/fdmt.md) | COMM | $3.4m | 1.8% | 252,654 |  | Reduced −127,766 |
| [OVID THERAPEUTICS INC (OVID)](/companies/ovid.md) | COMM | $3.0m | 1.6% | 1,115,538 |  | Added +194,081 |
| [EYEPOINT INC (EYPT)](/companies/eypt.md) | COMM | $2.7m | 1.4% | 191,745 |  | Reduced −24,080 |
| [UPSTREAM BIO INC (UPB)](/companies/upb.md) | COMM | $2.4m | 1.3% | 350,389 |  | Added +8,610 |
| [SCYNEXIS INC (SCYX)](/companies/scyx.md) | COMM | $2.2m | 1.2% | 543,478 |  | New +543,478 |
| [SILENCE THERAPEUTICS PLC (SLN)](/companies/sln.md) | ADRS | $2.1m | 1.1% | 191,733 |  | New +191,733 |
| [LEONABIO INC (LONA)](/companies/lona.md) | COMM | $1.4m | 0.7% | 149,279 |  | Unchanged |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COMM | $1.3m | 0.7% | 43,798 |  | Unchanged |
| [CORVUS PHARMACEUTICALS INC (CRVS)](/companies/crvs.md) | COMM | $1.1m | 0.6% | 70,380 |  | Reduced −15,411 |
| [SAGIMET BIOSCIENCES INC-A (SGMT)](/companies/sgmt.md) | COMM | $973.0k | 0.5% | 125,878 |  | New +125,878 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ALDEYRA THERAPEUTICS INC (ALDX)](/companies/aldx.md) | COM | $0 | 0.0% | 0 |  | Sold out −730,606 |
| [COHERUS ONCOLOGY INC (CHRS)](/companies/chrs.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,420,550 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | $0 | 0.0% | 0 |  | Sold out −209,493 |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $0 | 0.0% | 0 |  | Sold out −55,664 |
| IMMUNIC INC | COM | $0 | 0.0% | 0 |  | Sold out −2,344,779 |
| [KALARIS THERAPEUTICS INC (KLRS)](/companies/klrs.md) | COM | $0 | 0.0% | 0 |  | Sold out −295,771 |
| [NUVATION BIO INC (NUVB)](/companies/nuvb.md) | COM CL A | $0 | 0.0% | 0 |  | Sold out −329,296 |
| OCULIS HOLDING AG | ORDINARY SHARES | $0 | 0.0% | 0 |  | Sold out −122,223 |
| [SATELLOS BIOSCIENCE INC (MSLE)](/companies/msle.md) | COM | $0 | 0.0% | 0 |  | Sold out −10,145 |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $0 | 0.0% | 0 |  | Sold out −223,802 |
| UNIQURE NV | SHS | $0 | 0.0% | 0 |  | Sold out −104,772 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $0 | 0.0% | 0 |  | Sold out −210,163 |
| [VOR BIOPHARMA INC (VOR)](/companies/vor.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −314,543 |

Source: SEC EDGAR, Form 13F-HR, accession 0001829126-26-008753. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.